(Photo Credit - Nick Youngson)
Investors in marijuana-related stocks should always keep an eye out for earnings releases and conference calls regarding the companies they're holding in their portfolio. Whether you're an existing or prospective investor in GW Pharmaceuticals Plc. (NASDAQ:GWPH), you should mark the cannabinoid pharmaceutical company's upcoming earnings release in your calendar.
Related: GW Pharma Appoints New Managment
GWPH is a biotech / pharmaceutical company focused on researching and developing cutting-edge therapeutics from its proprietary cannabinoid product platform for a broad range of diseases and ailments. GW commercialized the world’s first plant-derived cannabinoid prescription drug, called Sativex, which is approved for the treatment of spasticity due to multiple sclerosis in 31 countries outside of the U.S.
Related: GWPH's Epidiolex Drug Receives Orphan Drug Designation
GW Pharmaceuticals will be reporting its Q3'17 earnings on Monday, August 7, 2017 just following the North American market close. Take note that there will also be a shareholder call to follow at 4:30 PM EST where management will provide additional color on the company's financials, developments, and more.
Related: Scotts Miracle-Gro's Upcoming Earnings Info
Don't forget to mark your calendars if GW Pharma is one of your holdings, or if you are considering making an investment. Be sure to subscribe to one or more of our free e-mail newsletters so that you never miss an important cannabis update. Also, don't forget to connect with The Daily Marijuana Observer via social media on Facebook, Twitter, StockTwits, and Instagram.